Last reviewed · How we verify

NCT04729504

Cultural Adaptation of a SSI for Youth Anxiety

Recruiting now NA Last updated 18 December 2025
What this trial tests

NA trial testing Adapted Project BRAVE in Anxiety Disorders in 2,000 participants. Currently enrolling.

Timeline
8 March 2021
Primary endpoint
21 December 2026
21 December 2026

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment2,000
Start date8 March 2021
Primary completion21 December 2026
Estimated completion21 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, any sex, with Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching objective of this protocol is to (1) adapt and (2) disseminate an evidence-based, brief (approximately 30 minute) single session intervention (SSI) to better reflect the cultural and linguistic diversity of Latin, Haitian, and Haitian-American individuals via a fully online platform.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anxiety Disorders

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04729504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing